- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Enorama Pharma AB (ERMA)
Enorama Pharma AB stock price live, this page displays ST ERMA stock exchange data. View the ERMA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Enorama Pharma AB real time stock price chart below.
What Is the Enorama Pharma AB Stock Price Today?
The Enorama Pharma AB stock price today is 0.810.
What Is the Stock Symbol for Enorama Pharma AB?
The stock symbol for Enorama Pharma AB is "ERMA."
What Stock Exchange Does Enorama Pharma AB Trade On?
Enorama Pharma AB is listed and trades on the Stockholm stock exchange.
Is Enorama Pharma AB a Good Stock to Buy?
Determining whether Enorama Pharma AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ERMA quote. (ISIN: SE0008216329)
What Is the Enorama Pharma AB Stock Price Today?
The Enorama Pharma AB stock price today is 0.810.
What Is the Stock Symbol for Enorama Pharma AB?
The stock symbol for Enorama Pharma AB is "ERMA."
What Stock Exchange Does Enorama Pharma AB Trade On?
Enorama Pharma AB is listed and trades on the Stockholm stock exchange.
Is Enorama Pharma AB a Good Stock to Buy?
Determining whether Enorama Pharma AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ERMA quote. (ISIN: SE0008216329)
Stockholm
Currency in SEK
0.810
-0.415(-33.88%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.810
1.260
52 wk Range
0.211
3.000
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.8101.260
52 wk Range
0.2113.000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ERMA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Earnings
Latest Release
May 20, 2026
EPS / Forecast
-0.17 / --
Revenue / Forecast
-108K / --
Compare ERMA to Peers and Sector
Metrics to compare | ERMA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipERMAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.4x | 0.0x | −0.3x | |
PEG Ratio | −0.10 | 0.00 | 0.00 | |
Price/Book | −2.5x | 0.0x | 2.6x | |
Price / LTM Sales | 41.9x | 0.0x | 3.1x | |
Upside (Analyst Target) | - | 0.0% | 49.0% | |
Fair Value Upside | Unlock | 0.0% | 6.3% | Unlock |
Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells tobacco-free white snus in Sweden. It offers its products under the NIC-S brand name. The company was incorporated in 2006 and is based in Stockholm, Sweden.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Enorama Pharma (ERMA) Stock Price Today?
The Enorama Pharma stock price today is 0.810 SEK.
What Stock Exchange Does Enorama Pharma Trade On?
Enorama Pharma is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for Enorama Pharma?
The stock symbol for Enorama Pharma is "ERMA."
What Is the Enorama Pharma Market Cap?
As of today, Enorama Pharma market cap is 91.370M SEK.
What Is Enorama Pharma's Earnings Per Share (TTM)?
The Enorama Pharma EPS (TTM) is -0.896.
From a Technical Analysis Perspective, Is ERMA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Enorama Pharma Stock Split?
Enorama Pharma has split 1 times.
How Many Employees Does Enorama Pharma Have?
Enorama Pharma has 4 employees.
What is the current trading status of Enorama Pharma (ERMA)?
As of Aug 18, 2026, Enorama Pharma (ERMA) is trading at a price of 0.810 SEK, with a previous close of 1.225 SEK. The stock has fluctuated within a day range of 0.810 SEK to 1.260 SEK, while its 52-week range spans from 0.211 SEK to 3.000 SEK.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.